ING Bank Netherlands Says Fed Rate Hike Expectations Support Continued Strength of the Dollar
智通财经2026/10/08 08:01ING analyst Chris Turner stated that the Federal Reserve's September meeting minutes indicate the Fed still expects another interest rate hike this year, which continues to support the US dollar. Currently, the money market has priced in a 25 basis point rate hike in December and further policy tightening expected in 2027. ING believes that the market's expectations for rate hikes are overly aggressive, but a significant correction is unlikely in the short term. In addition, last night’s US 10-year Treasury auction performed strongly, with a high bid-to-cover ratio and robust indirect demand, indicating that as long as yields are high enough, there remains strong market demand for US Treasuries. This has provided solid support for the US dollar and has further boosted it in a somewhat challenging investment environment. Elevated US Treasury yields and increased market volatility have led to capital outflows from arbitrage trades, significantly impacting most Latin American currencies. Given the recent situation in Europe, we expect the US dollar to maintain its upward trend in the coming months.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ-Applied Digital shares surge as Q1 revenue quadruples
October 8 - ** Data center service provider Applied Digital (APLD.O) saw its stock rise 3.57% in pre-market trading to $24.66 ** The company’s Q1 revenue (link) surged more than fourfold to $341.9 millions, far surpassing analyst estimates of $133.8 millions ** Northland Capital Securities noted that APLD’s revenue and cash flow should increase significantly in the coming years as contracted data center capacity becomes operational and starts generating income ** Net loss attributable to common shareholders widened from $18.5 millions (7 cents/share) a year ago to $221 millions (76 cents/share) ** According to data compiled by London Stock Exchange Group (LSEG), the average rating from 17 analysts covering the stock is “Buy”, with a median target price of $70.00, representing an upside of about 194% from the current price ** Year-to-date, the stock is down about 2.9%, while the Nasdaq Index .IXIC is up 18.5% over the same period. (For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Since automated translation may contain errors or lack necessary context, Reuters does not guarantee the accuracy of automated translation and provides it only as a convenience. Reuters assumes no liability for any damage or loss resulting from the use of automated translation.)
WTI crude oil rises above $91 per barrel, up 3.02% intraday
WTI crude oil rose above $91 per barrel for the first time since October 2, with a daily increase of 3.02%.
AstraZeneca (AZN.US) and Daiichi Sankyo (DSNKY.US) TROP2 ADC receives approval for new indication in China
According to information from Zhihu Finance APP, AstraZeneca (AZN.US) and Daiichi Sankyo (DSNKY.US) have announced that Datroway® (generic name: datopotamab deruxtecan for injection) has been approved by the National Medical Products Administration (NMPA) of China for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (TNBC) who are not suitable for PD-1/PD-L1 inhibitor therapies. Datopotamab deruxtecan is an antibody-drug conjugate (ADC) targeting TROP2, developed with proprietary technology by Daiichi Sankyo, and jointly developed and commercialized by AstraZeneca and Daiichi Sankyo.
Abu Dhabi National Oil Company invites bids for crude oil cargo shipments
Trader: Abu Dhabi National Oil Company issued a tender this week to sell crude oil for December loading or January delivery.
Crypto prices
More
